Lower-risk Myelodysplastic Syndromes: Data Updates and Evolving Treatment Paradigms in the Frontline Setting

home / insights / lower-risk-myelodysplastic-syndromes-data-updates-and-evolving-treatment-paradigms-in-the

Two expert oncologists review the standard-of-care and unmet needs in the treatment of lower-risk Myelodysplastic Syndromes [MDS]. They discuss emerging data on novel therapies and consider their impact on the treatment landscape for patients with lower-risk MDS.

EP. 1: Risk Stratification of Myelodysplastic Syndromes [MDS]

Ralph Boccia, MD, Johns Hopkins Medicine;Hetty Carraway, MD

June 15th 2023

Ralph Boccia, MD, FACP, and Hetty Carraway, MD, review Myelodysplastic Syndromes [MDS] risk stratification criteria used in their practices.

EP. 2: Importance of Early Diagnosis of MDS for Lower and Higher-risk Patients

Ralph Boccia, MD, Johns Hopkins Medicine;Hetty Carraway, MD

June 15th 2023

Hetty Carraway, MD, highlights the importance of early diagnosis across all patients with MDS.

EP. 3: Frontline Treatment Options for Lower-Risk MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

June 22nd 2023

Expert oncologists discuss standard-of-care frontline treatments for patients with lower-risk MDS.

EP. 4: Clinical Use of Luspatercept on Patients with Lower-risk MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

June 22nd 2023

Ralph Boccia, MD, FACP, shares his clinical experience using luspatercept to treat patient with lower-risk MDS.

EP. 5: Safety and Efficacy of Luspatercept in Frontline Setting in Patients with MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

June 29th 2023

Oncologists review study design and discuss key safety and efficacy data of the COMMANDS trial investigating luspatercept in frontline setting in patients with lower-risk MDS.

EP. 6: Emerging Therapies for Treatment of MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

June 29th 2023

Expert oncologists discuss management strategies for patients with lower-risk MDS considering upcoming treatment options.

EP. 7: Clinical Management of Patients with Lower-risk MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

July 6th 2023

Ralph Boccia, MD, FACP, highlights emerging therapies and the importance of next-generation sequencing for patients with MDS.

EP. 8: Unmet Needs and Future Perspectives in Treatment of MDS

Ralph V. Boccia, MD, FACP, LLC, Georgetown University Medical Center;Hetty Carraway, MD

July 6th 2023

Expert oncologists discuss unmet needs and share final thoughts on the future of treatment of patients with lower-risk MDS.